|
|
|
By Maria Gonzalez-Gancedo, Elvira Mukharryamova, and Ivo Carre, Lifescience Dynamics | New treatment/targeting methods for Guillain-Barre Syndrome and Huntington’s Disease, CIDP, and ALS are seeing clinical trial success, according to updates shared at the 2025 American Academy of Neurology conference in early April. | |
|
|
|
|
|
|
| Optimizing T-Cell Expansion Using DoE And Process Transfer | Poster | By Julia Hupfeld, Alison Rees-Manley, Martin Albersdoerfer, and Alexander Tappe, Sartorius | Manufacturing CAR-T cells is challenging, but crucial. Discover how stirred culture systems paired with an innovative platform and software can accelerate development and enhance process understanding. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|